ArticleSkeletal radiology2026
CIC-rearranged sarcoma of the arm presenting as a soft tissue mass with regional lymphadenopathy and tumor thrombus.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capicua transcriptional repressor (CIC)-rearranged sarcoma is an aggressive and rare small round cell tumor predominantly affecting the soft tissues of extremities, often with early metastasis and poor prognosis. We report a case of a 46-year-old female presenting with a CIC-rearranged sarcoma of the right arm, notably complicated by extensive tumor thrombus involving the brachial, axillary, and subclavian veins, extending into the internal jugular vein, and regional lymphadenopathy. While tumor thrombus in CIC-rearranged sarcoma has been described in several abdominal cases, this is the first case described in the extremity, to the best of our knowledge. This case highlights the challenges in diagnosing this rare entity, the critical role of molecular confirmation, and the unusual presentation of widespread venous involvement, impacting staging and treatment considerations.
Indexed as
Identifiers
42850403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.